Effects of chlorpyrifos on non-cholinergic toxicity endpoints in immortalized and primary rat hepatocytes under normal and hepatosteatotic conditions
- 11 February 2022
- journal article
- research article
- Published by Elsevier in Toxicology in Vitro
- Vol. 80, 105329
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Lumenal Lipid MetabolismArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxonToxicology and Applied Pharmacology, 2012
- Effect of Developmental Chlorpyrifos Exposure, on Endocannabinoid Metabolizing Enzymes, in the Brain of Juvenile RatsToxicological Sciences, 2011
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced trans-activating capacity of LXRαBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Extreme variability in the formation of chlorpyrifos oxon (CPO) in patients poisoned by chlorpyrifos (CPF)Biochemical Pharmacology, 2009
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in miceJournal of Clinical Investigation, 2008
- Activation of the endocannabinoid system by organophosphorus nerve agentsNature Chemical Biology, 2008
- A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-ArachidonoylglycerolChemistry & Biology, 2007
- Serine hydrolase targets of organophosphorus toxicantsChemico-Biological Interactions, 2005